Zobrazeno 1 - 10
of 14 821
pro vyhledávání: '"GLP-1R"'
Autor:
Liu, Chenyang1 (AUTHOR), Zhang, Qun1 (AUTHOR), Zhou, Hong2 (AUTHOR), Jin, Linling1 (AUTHOR), Liu, Chang1 (AUTHOR), Yang, Mingxia3 (AUTHOR), Zhao, Xinyun1 (AUTHOR), Ding, Wenqiu1 (AUTHOR), Xie, Weiping1 (AUTHOR) wpxie@njmu.edu.cn, Kong, Hui1 (AUTHOR) konghui@njmu.edu.cn
Publikováno v:
Journal of Translational Medicine. 10/21/2024, Vol. 22 Issue 1, p1-21. 21p.
Autor:
Reed, Joshua1 (AUTHOR) joshjreed@hotmail.co.uk, Higginbotham, Victoria1 (AUTHOR), Bain, Stephen1 (AUTHOR), Kanamarlapudi, Venkateswarlu1 (AUTHOR) k.venkateswarlu@swansea.ac.uk
Publikováno v:
International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6331. 19p.
Autor:
Bosch, Rolien1,2 (AUTHOR) r.bosch@erasmusmc.nl, Sijbrands, Eric J. G.2 (AUTHOR), Snelder, Nelleke1 (AUTHOR)
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology. Sep2024, Vol. 13 Issue 9, p1488-1502. 15p.
Autor:
Chenyang Liu, Qun Zhang, Hong Zhou, Linling Jin, Chang Liu, Mingxia Yang, Xinyun Zhao, Wenqiu Ding, Weiping Xie, Hui Kong
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-21 (2024)
Abstract Background Pulmonary fibrosis is a serious interstitial lung disease with no viable treatment except for lung transplantation. Glucagon-like peptide-1 receptor (GLP-1R), commonly regarded as an antidiabetic target, exerts antifibrotic effect
Externí odkaz:
https://doaj.org/article/cf5a36068247478eb83c87e47a109837
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abiola, Julianah Ore1,2,3 (AUTHOR) j.orefatunmibi@gmail.com, Oluyemi, Ayoola Abidemi3 (AUTHOR), Idowu, Olajumoke Tolulope4 (AUTHOR), Oyinloye, Oluwatoyin Mary5 (AUTHOR), Ubah, Chukwudi Sunday6 (AUTHOR), Owolabi, Olutunmise Victoria7 (AUTHOR), Somade, Oluwatobi T.1,8 (AUTHOR), Onikanni, Sunday Amos1,9 (AUTHOR), Ajiboye, Basiru Olaitan3,10 (AUTHOR), Osunsanmi, Foluso Oluwagbemiga11 (AUTHOR), Nash, Oyekanmi2 (AUTHOR), Omotuyi, Olaposi Idowu3,12 (AUTHOR), Oyinloye, Babatunji Emmanuel1,3,11 (AUTHOR) babatunjioe@abuad.edu.ng
Publikováno v:
Pharmaceuticals (14248247). Jun2024, Vol. 17 Issue 6, p736. 22p.
Autor:
Na Liu, Xin Cui, Wenhui Yan, Tingli Guo, Zhuanzhuan Wang, Xiaotong Wei, Yuzhuo Sun, Jieyun Liu, Cheng Xian, Weina Ma, Lina Chen
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 14, Iss 8, Pp 100968- (2024)
There is increasing evidence that the activation of glucagon-like peptide-1 receptor (GLP-1R) can be used as a therapeutic intervention for cognitive disorders. Here, we have screened GLP-1R targeted compounds from Scutellaria baicalensis, which reve
Externí odkaz:
https://doaj.org/article/0b77bb30e444440c879859b2c5637d82
Autor:
Emma Barrett, Gabrielle Ivey, Adam Cunningham, Gary Coffman, Tyera Pemberton, Chan Lee, Prabir Patra, James B. Day, Peter H. U. Lee, Joon W. Shim
Publikováno v:
Frontiers in Aging Neuroscience, Vol 16 (2024)
The glucagon-like peptide-1 receptor (GLP-1R) agonists reduce glycated hemoglobin in patients with type 2 diabetes. Mounting evidence indicates that the potential of GLP-1R agonists, mimicking a 30 amino acid ligand, GLP-1, extends to the treatment o
Externí odkaz:
https://doaj.org/article/a2169a78ce0d4aaba362d9008ac9c48e